arrow
N

Noelia Tarazona

instituto de salud carlos iii
H指数:27
被引数:2,749

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial

循环肿瘤DNA指导的高风险II期和III期结肠癌辅助治疗降级或升级:PEGASUS II期试验

2026-09-140
OAAI
A radiomics-based artificial intelligence model to assess the risk of relapse in localized colon cancer

一种基于放射组学的人工智能模型,用于评估局部结肠癌的复发风险

2025-07-160
OAAI
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)

ESMO临床获益程度量表2.0版(ESMO-MCBS v2.0)

2025-05-220
PRE
Extended tumor area-based stratification score combining tumor budding and stroma identifies a high-risk, immune-depleted group in localized microsatellite-stable colon cancer patients

基于扩展肿瘤区域并结合肿瘤出芽和间质的分层评分可识别局部微卫星稳定型结直肠癌患者中的高风险、免疫耗竭组

2025-05-010
PRE
Prognostic value of routine blood biomarkers in 3-year survival of resectable colorectal cancer patients: a prognostic nomogram for clinical practice

可切除结直肠癌患者3年生存率的常规血液生物标志物预测价值:临床实践中的预后列线图

2025-03-050
OA
Decoding chromosomal instability insights in CRC by integrating omics and patient-derived organoids

通过整合组学和患者源性类器官解码结直肠癌中的染色体不稳定性见解

2025-02-280
OA
ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and identifies actionable alterations in fast progressing patients
2024-09-011
PRE
Sequencing paired tumor DNA and white blood cells improves circulating tumor DNA tracking and detects pathogenic germline variants in localized colon cancer
2023-12-014
OAAI
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy
2023-02-1038
OAAI
Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction

用于药物敏感性预测的晚期结直肠癌患者衍生的类器官的蛋白质转录组学分析

2023-01-0629
OAAI
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
2022-10-173
OA
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+breast tumors
2022-09-0928
OAAI